Antihypertensive therapy and the risk of new-onset diabetes von Sarafidis, Panteleimon A, Bakris, George L

Volltext

The metabolic syndrome: a glance at its history von Sarafidis, Panteleimon A, Nilsson, Peter M

Volltext

Actions of Peroxisome Proliferator–Activated Receptors–γ Agonists Explaining a Possible Blood Pressure–Lowering Effect von Sarafidis, Panteleimon A., Lasaridis, Anastasios N.

Volltext

Diabetic nephropathy and antihypertensive treatment: what are the lessons from clinical trials? von Lasaridis, Anastasios N, Sarafidis, Panteleimon A

Volltext

Level of kidney function determines cardiovascular fate after coronary bypass graft surgery von Sarafidis, Panteleimon A, Bakris, George L

Volltext

Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase von Sarafidis, Panteleimon A, Lasaridis, Anastasios N, Nilsson, Peter M, Pagkalos, Emmanuil M, Hitoglou-Makedou, Areti D, Pliakos, Christodoulos I, Kazakos, Kiriakos A, Yovos, John G, Zebekakis, Pantelis E, Tziolas, Ioannis M, Tourkantonis, Achilleas N

Volltext

The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension von Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Nilsson, Peter M., Hitoglou-Makedou, Areti D., Pagkalos, Emmanuil M., Yovos, John G., Pliakos, Christodoulos I., Tourkantonis, Achilleas A.

Volltext

Do the Metabolic Effects of β Blockers Make Them Leading or Supporting Antihypertensive Agents in the Treatment of Hypertension? von Sarafidis, Panteleimon A., Bakris, George L.

Volltext

The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension : An open-label observational study von SARAFIDIS, Panteleimon A, LASARIDIS, Anastasios N, NILSSON, Peter M, MOUSLECH, Tzant F, HITOGLOU-MAKEDOU, Areti D, STAFYLAS, Panagiotis C, KAZAKOS, Kiriakos A, YOVOS, John G, TOURKANTONIS, Achilleas A

Volltext

Are β Blockers Passé for the Treatment of Hypertension? von Sarafidis, Panteleimon A., Bakris, George L.

Volltext

An Economic Evaluation of the 2003 European Society of Hypertension–European Society of Cardiology Guidelines for the Management of Mild-to-Moderate Hypertension in Greece von Stafilas, Panagiotis C., Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Aletras, Vassilios H., Niakas, Dimitris A.

Volltext

P-649: Rosiglitazone lowers C-reactive protein levels in hypertensive type 2 diabetic patients von Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Stafilas, Panagiotis C., Makedou-Kourti, Kali, Zebekakis, Pantelis, Diamantopoulos, Athanasios, Tourkantonis, Achilleas

Volltext

P-606: Efficacy and costs of treatment of mild-to-moderate uncomplicated hypertension in Greece von Stafilas, Panagiotis C., Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Aletras, Vassilios H.

Volltext

P-607: Pharmacoeconomic analysis of antihypertensive agents in Greece von Stafilas, Panagiotis C., Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Aletras, Vassilios H., Zouka, Maria D.

Volltext

P-472: Coexistence of hypertension and hypercholesterolemia in employees of factories of northern greece von Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Gousopoulos, Stavros, Zebekakis, Pantelis E., Tziolas, Ioannis, Papoulidoy, Fani

Volltext

P-508: The effects of telmisartan and lercanidipine on blood pressure and insulin resistance in hypertensive patients von Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Hatzistavri, Lina, Zebekakis, Pantelis E., Tziolas, Ioannis, Diamantopoulos, Athanasios

Volltext

Actions of Peroxisome Proliferator-Activated Receptors-[gamma] Agonists Explaining a Possible Blood Pressure-Lowering Effect von Sarafidis, Panteleimon A, Lasaridis, Anastasios N

Volltext

Rosiglitazone Improves Insulin Sensitivity and Glycemic Control in Patients with Both Poorly Controlled Type 2 Diabetes and Hypertension von Sarafidis, Panteleimon A, Lasaridis, Anastasios N, Pagkalos, Emmanuil, Yovos, John

Volltext

The Effect of Rosiglitazone on Safety Parameters of Patients with Type 2 Diabetes and Hypertension von Sarafidis, Panteleimon A, Lasaridis, Anastasios, Yovos, John, Kazakos, Kiriakos

Volltext

Efficacy and costs of treatment of mild-to-moderate uncomplicated hypertension in Greece von Stafilas, Panagiotis C., Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Aletras, Vassilios H.

Volltext